Shinji Ashida

This inventor holds 17 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Antibody-Drug Conjugates. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shinji Ashida. Retrieved from https://idiyas.com/inventor/shinji-ashida

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 5)

% Patents Active = 94.1

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 8)

Average Co-Inventor Count = 10.3

ph-index = 6

Forward Citations = 113(Granted Patents)

Location History:

Chiba, JP (2014 - 2015)
Tokyo, JP (2017 - 2023)

Company Filing History:

17 out of 463

Daiichi Sankyo Company, Limited

patents

Years Active: 2014-2025

Loading Chart...

Areas of Expertise:

Claudin-6

Claudin-9

Pyrrolobenzodiazepine

Anti-HER2

Tumor Treatment

Cancer Therapy

Benzo[e]pyrrolo[1,2-a][1,4]diazepines

Piperazinyl Compounds

Linker Structures

Drug Conjugates

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12350344 - Methods of treating a tumor by administering a claudin-6 (CLDN6) or CLDN9 antibody-pyrrolobenzodiazepine derivative conjugate (2025-07-08),

2. 12246196 - Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-a][1,4]diazepines (2025-03-11),

3. 12186310 - Antibody-drug conjugate (2025-01-07),

4. 11795236 - Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugate (2023-10-24),

5. 11633493 - Antibody-drug conjugate (2023-04-25),

6. 11628223 - Antibody-drug conjugates comprising substituted benzo[e]pyrrolo[1,2-α][1,4]diazepines (2023-04-18),

7. 11584800 - Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugate (2023-02-21),

8. 11583590 - Antibody-pyrrolobenzodiazepine derivative conjugate and method of use thereof for treating a tumor (2023-02-21),

9. 11185594 - (Anti-HER2 antibody)-drug conjugate (2021-11-30),

10. 10973924 - Antibody-drug conjugate (2021-04-13),

11. 10729782 - Antibody-drug conjugate produced by binding through linker having hydrophilic structure (2020-08-04),

12. 10195288 - Antibody-drug conjugate (2019-02-05),

13. 10155821 - Anti-HER2 antibody-drug conjugate (2018-12-18),

14. 9872924 - Antibody-drug conjugate produced by binding through linker having hydrophilic structure (2018-01-23),

15. 9808537 - Antibody-drug conjugate (2017-11-07),

Title: Shinji Ashida - Innovative Inventor from Tokyo

Introduction: Shinji Ashida is a renowned inventor hailing from Tokyo, Japan, known for his groundbreaking contributions to various technological fields.

Latest Patents: Shinji Ashida holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his continuous innovation and forward-thinking approach.

Career Highlights: With over two decades of experience in the tech industry, Ashida has worked with leading research institutions and universities to develop cutting-edge solutions that have revolutionized the way we interact with technology.

Collaborations: Throughout his career, Shinji Ashida has collaborated with top companies and inventors worldwide, fostering a culture of innovation and knowledge sharing that has led to significant advancements in the field.

Conclusion: Shinji Ashida's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the future of technology in Japan and beyond.

Profile summary based on public USPTO records.